Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding
- 5 March 2015
- journal article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 21 (3), 217-219
- https://doi.org/10.1038/nm.3810
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseAlzheimer's & Dementia, 2014
- A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal FluidJournal of Neuroscience, 2014
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s DiseasePLOS ONE, 2013
- Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s DiseasePLOS ONE, 2013
- Plasma tau levels in Alzheimer's diseaseAlzheimer's Research & Therapy, 2013
- New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSFAlzheimer's & Dementia, 2013
- Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot studyResuscitation, 2012
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrationsNature Biotechnology, 2010
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010